Stonarhini Tablet
FDA Label NDC 49873-109

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sato Pharmaceutical Co., Ltd. for the product Stonarhini (NDC 49873-109). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings​, otc - do not use, otc - ask doctor, otc - ask doctor/pharmacist, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredients (In each tablet)        
Chlorpheniramine Maleate 2 mg    
Phenylephrine HCl 5 mg

Otc - Purpose

Purpose
Chlorpheniramine Maleate    Antihistamine
Phenylephrine HCl        Nasal decongestant

Indications & Usage

Uses
Temporarily relieves these symptoms due to common cold, hay fever or other upper respiratory allergies (allergic rhinitis).
■ sneezing        ■ runny nose    ■ itchy, watery eyes
■ nasal congestion, stuffy nose        ■ itchy throat

Warnings​

Enter section text here

Otc - Do Not Use

Do not use this product
■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease) or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription contains an MAOI, ask a doctor or pharmacist before taking this priduct.

Otc - Ask Doctor

Ask a doctor before use if you have
■ a breathing problem such as emphysema or chronic bronchitis
■ glaucoma    ■ heart disease    ■ thyroid disease
■ diabetes    ■ high blood pressure
■difficulty in urination due to enlargement of the prostate

Otc - Ask Doctor/Pharmacist

Ask a doctor or pharmacist before use
■ if you are taking sedatives or tranquilizers

Otc - When Using

When using this product
■ do not exceed recommended dosage.  If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor.
■ you may get drowsy.
■ may cause excitability, especially in children.
■ alcohol, sedatives and tranquilizers may increase the drowsiness effect.
■ avoid alcoholic beverages.
■ use caution when driving a motor vehicle or operating machinery.

Otc - Stop Use

Stop use and ask a doctor if
■ symptoms do not improve within seven days
■ symptoms are accompanied by fever

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.  Prompt attention is critical even if you do not notice any signs or symptoms.

Dosage & Administration

Directions
adults and children 12 years and over:  2 tablets every 4 hours, not to exceed 12 tablets in 24 hours
children under 12 years of age:  ask a doctor

Inactive Ingredient

Inactive ingredients  aspartame, colloidal silicone dioxide, FD&C Red No. 40 aluminum Lake, flavor, hydroxypropyl cellulose, magnesium stearate, mannitol.

Package Label.Principal Display Panel

Carton (Stonarcartv2)

Carton (Stonarcartv2)

* Please review the disclaimer below.